ReposiTrak, Inc. announces quarterly cash dividend
ReposiTrak, Inc., a leading provider of food traceability and regulatory compliance solutions, announced today the declaration of a quarterly cash dividend of $0.01815 per quarter ($0.0726 per share annually) to be paid to shareholders of record on June 30, 2025. This dividend will be disbursed to eligible shareholders on or around August 14, 2025.
In a significant move towards rewarding shareholders, ReposiTrak plans to increase the quarterly cash dividend by 10% starting with the next payment scheduled for on or about November 14, 2025. Shareholders of record as of September 30, 2025, will receive a dividend of $0.02 per quarter ($0.08 annually), marking the third increase in dividends since the dividend’s initiation. Subsequent dividends will be paid within 45 days of the end of each fiscal quarter.
As a global leader in food traceability and compliance solutions, ReposiTrak (NYSE: TRAK) serves retailers, suppliers, food manufacturers, and wholesalers with a comprehensive suite of tools aimed at mitigating risks, ensuring compliance with regulations, enhancing operational controls, and boosting sales while safeguarding brand integrity. ReposiTrak offers three distinct product families: food traceability, compliance and risk management, and supply chain solutions. These integrated, cloud-based applications are backed by a team of experts dedicated to supporting their clients.
Regarding forward-looking statements, ReposiTrak emphasizes that any statements contained in this press release that are not historical facts should be viewed as forward-looking statements as per the U.S. Private Securities Litigation Reform Act of 1995. Terms such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if”, “should,” and “will” are intended to identify such forward-looking statements. ReposiTrak reserves the right to update these projections but is not obligated to do so. While every effort is made to project future operational results accurately, these projections are subject to change and may differ significantly from final reported results. Risks and uncertainties related to such projections are discussed in the company’s filings with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are advised to exercise caution and avoid placing undue reliance on these forward-looking statements, as they are only valid as of their publication dates.